Santhera Pharmaceuticals Holding AG (SANN.SW) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Switzerland · ISIN CH1276028821
Santhera Pharmaceuticals Holding AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 39.12 m CHF | 77.19 m CHF |
| Gross profit | 22.96 m CHF | 14.47 m CHF |
| Operating income | -33.38 m CHF | -37.82 m CHF |
| EBIT | -21.53 m CHF | -37.82 m CHF |
| Net income | -41.97 m CHF | -49.24 m CHF |
| Diluted EPS – continuing operations | -3.69 CHF | -3.78 CHF |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
More stocks
- T&L Co. Ltd (340570.KQ)
- Norsyn Crop Technology Co. Ltd. A (001231.SZ)
- LCNB CORP (LCNB)
- Instone Real Estate Group (INS.DE)
- INTERNATIONAL TOWER HILL MINES LTD (THM)
- JACK IN THE BOX INC (JACK)
- FRIEDMAN INDUSTRIES INC (FRD)
- Silver Tiger Metals Inc. (SLVR.TO)
- Jiangsu Topfly New Materials (001373.SZ)
- Indexa Capital Group, S.A. (INDXA.MC)
- Letong Chemical Co Ltd (002319.SZ)
- Zoy Home Furnishing Co Ltd (603709.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.